Inventor · disambiguated record
Joey L. Methot
Also filed as: METHOT JOEY · METHOT JOEY L · METHOT JOEY LEE
32 granted patents·10 pending applications·157 citations·filing 2005–2023
96Inventor score
Files withMERCK SHARP & DOHME16MERCK SHARP & DOHME LLC9BERTHELETTE CARL2BOYCE CHRISTOPHER W2FISCHER CHRISTIAN2
Top patents by PatentIndex Score
42 records- 0193US7544695B2Spirocyclic compoundsMERCK & CO INC·Filed 2006·Granted Jun 9, 2009·29 cites·14 claims
- 0291US8686020B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2012·Granted Apr 1, 2014·17 cites·6 claims
- 0391US8349825B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2010·Granted Jan 8, 2013·18 cites·6 claims
- 0490US7834026B2Spirocyclic compoundsMERCK SHARP & DOHME·Filed 2006·Granted Nov 16, 2010·17 cites·6 claims
- 0586US8242150B2Triazole derivatives for treating alzheimer'S disease and related conditionsFISCHER CHRISTIAN·Filed 2008·Granted Aug 14, 2012·12 cites·10 claims
- 0686US8119685B2Disubstituted aniline compoundsHEIDEBRECHT RICHARD·Filed 2007·Granted Feb 21, 2012·18 cites·10 claims
- 0783US9221809B2Aminopyrimidinones as interleukin receptor-associated kinase inhibitorsMERCK SHARP & DOHME·Filed 2012·Granted Dec 29, 2015·4 cites·3 claims
- 0881US9023865B2Compounds that are ERK inhibitorsLIM JONGWON·Filed 2012·Granted May 5, 2015·4 cites·20 claims
- 0981US8394819B2Indole derivatives as CRTH2 receptor antagonistsBERTHELETTE CARL·Filed 2010·Granted Mar 12, 2013·8 cites·22 claims
- 1078US12030872B2N-heteroaryl indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2019·Granted Jul 9, 2024·2 cites·15 claims
- 1178US11161854B2Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1278US8927559B2Quinazolinone-type compounds as CRTH2 antagonistsASLANIAN ROBERT G·Filed 2011·Granted Jan 6, 2015·6 cites·16 claims
- 1377US7772238B2Benzothiophene hydroxamic acid derivativesMERCK SHARP & DOHME·Filed 2006·Granted Aug 10, 2010·4 cites·15 claims
- 1473US9884048B2ERK inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Feb 6, 2018·2 cites·6 claims
- 1573US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 1672US9469615B2Quinoxalines and AZA-quinoxalines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Oct 18, 2016·4 cites·27 claims
- 1771US9169260B2Amidopyrazole inhibitors of interleukin receptor-associated kinasesMCELROY WILLIAM T·Filed 2012·Granted Oct 27, 2015·4 cites·7 claims
- 1871US8119652B2Aryl-fused spirocyclic compoundsHAMBLETT CHRISTOPHER·Filed 2007·Granted Feb 21, 2012·3 cites·6 claims
- 1970US2025326766A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2070US2024025912A1Ripk1 inhibitors and methods of useMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 2157US12180226B2Spirotricycle RIPK1 inhibitors and methods of uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 31, 2024·0 cites·27 claims
- 2256US2024208986A1Phenyl azepines as ripk1 inhibitors and methods of use thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2356US2024228506A1Ripk1 inhibitors and methods of useDIMAURO ERIN F·Filed 2022·Application pending·0 cites
- 2456US2024425524A1Spirotricycle ripk1 inhibitors and methods of uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2555US2024308980A1Heteroaryl amides as lrrk2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2652US2023399341A17-phenyl substituted 2-aminoquinazoline inhibitors of hpk1MERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2751US11179389B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2018·Granted Nov 23, 2021·0 cites·13 claims
- 2849US2023406864A17-azole substituted 2-aminoquinazoline inhibitors of hpk1MERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2948US9023864B2Indole derivatives as CRTH2 receptor antagonistsBERTHELETTE CARL·Filed 2013·Granted May 5, 2015·0 cites·10 claims
- 3048US8575150B2Triazole derivatives for treatment of Alzheimer's diseaseFISCHER CHRISTIAN·Filed 2009·Granted Nov 5, 2013·0 cites·8 claims
- 3146US11174248B2Indazolyl-spiro[2.3]hexane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereofMERCK SHARP & DOHME·Filed 2018·Granted Nov 16, 2021·0 cites·11 claims
- 3245US7872024B2Benzothiophene hydroxamic acid derivatives with carbamate, urea, amide and sulfonamide substitutionsMERCK SHARP & DOHME·Filed 2006·Granted Jan 18, 2011·0 cites·17 claims
- 3344US2011130361A1Silicon derivatives as histone deacetylase inhibitorsGRIMM JONATHAN·Filed 2008·Application pending·0 cites
- 3443US11230547B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2018·Granted Jan 25, 2022·0 cites·3 claims
- 3543US7534918B2Histone deacetylase inhibitorsMERCK & CO INC·Filed 2005·Granted May 19, 2009·0 cites·17 claims
- 3641US9938281B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·0 cites·18 claims
- 3741US9233979B2Compounds that are ERK inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Jan 12, 2016·0 cites·16 claims
- 3838US9290453B2Quinolines and aza-quinolines as CRTH2 receptor modulatorsBOYCE CHRISTOPHER W·Filed 2011·Granted Mar 22, 2016·0 cites·12 claims
- 3938US2009105264A1Substituted Nicotinamide CompoundsHAMBLETT CHRISTOPHER·Filed 2006·Application pending·0 cites
- 4037US10544147B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2017·Granted Jan 28, 2020·0 cites·25 claims
- 4134US10221178B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·0 cites·15 claims
- 4230US8871796B2Diaryl ether derivatives as notch sparing gamma secretase inhibitorsBROWN WILLIAM COLBY·Filed 2010·Granted Oct 28, 2014·0 cites·17 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →